Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis

American Journal of Reproductive Immunology

Volumn 59, Issue 6, 2008, Pages 535-544

  Wicherek, Lukasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Endometriosis; Endometrium; sRCAS1

Indexed keywords

RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL; TUMOR ANTIGEN;

ADENOMYOSIS; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CELLULAR IMMUNITY; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DECIDUALIZATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; DISEASE PROGRESSION; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNE TOLERANCE; MENSTRUAL CYCLE; OVARIAN DISEASES;

EID: 43849101972     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00584.x     Document Type: Article

References (61)

1. Valle RF:CEndometriosis: current concepts and therapy. Int J Gynaecol Obstet 2002; 78:107-119.
2. Ulukus M, Cakmak H, Arici A: The role of endometrium in edometriosis. J Soc Gynecol Investig 2006; 13:467-476.
3. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J: Endometriosis: harmful survival of an ectopic tissue. Front Biosci 2006; 11:595-619.
4. LeyendeckAr G, Kunz G, Noe M, Herbertz M, Mall G: Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998; 4:752-762.
5. Guo SW: Nuclear factor-κB (AF-κB): an unsuspected major culprit in the pathogenesis of endometriosis that is Still at Large? Gynecol Obstet Invest 2007; 63:71-97.
6. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D: Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006; 62:139-147.
7. Wu Y, Strawn E, Basir Z, Wang Y, Halverson G, Jailwala P, Guo SW: Genomic alterations in ectopic and eutopic endometria of women with endometriosis. Gynecol Obstet Invest 2006; 62:148-159.
8. Milingos S, Protopapas A, Kallipolitis G, Drakakis P, Loutradis D, Liapi A, Antsaklis A: Endometriosis in patients withIchronic pelvic pain: is staging predictive of the efficacy of laparoscopic surgery in pain relief? Gynecol Obstet Invest 2006; 62:48-54.
9. Sampson JA: Endometrial carcinoma of the ovary, arising in endometrial tissue of that organ. Arch Surg 1925; 10:1-72.
10. Witz CA: Current concepts in the pathogenesis of endometriosis. Clin Obstet Gynecol 1999; 42:566-585.
11. Thomakos N, Rodolakis A, Vlachos G, Papaspirou I, Markaki S, Antsaklis A: A rare case of rectovaginal endometriosis with lymph node involvement. Gynecol Obstet Invest 2006; 62:45-47.
12. Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril 2001; 75:1-10.
13. Vinatier D, Cosson M, Dufour P: Is endometriosis and endometrial disease?. Eur J Obstet Gynecol Reprod Biol 2000; 91:113-125.
14. Nap AW, Groothuis PG, Demir AY, Evers JL, Dunselman GA: Pathogenesis of endmetriosis. Best Pract Res Clin Obstet Gynaecol 2004; 18:233-244.
15. Koninckx PR, Oosterlynck D, D'Hooghe T, Meuleman C: Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease. Ann N Y Acad Sci 1994; 734:333-341.
16. Chao KH, Wu MY, Yang JH, Chen SU, Yang YS, Ho HN: Decreased expression of CD25 on decidual activated T lymphocytes is not mediated by reduced CD25 messenger ribonucleic acid. Fertil Steril 2007; 87:182-188.
17. Ugur Y, Cakar AN, Beksac MS, Dagdeviren A: Activation antigens during the proliferative and secretory phases of endometrium and early-pregnancy decidua. Gynecol Obstet Invest 2006; 62:66-74.
18. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Opławski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and the endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99:622-630.
19. Wicherek L, Dutsch-Wicherek M, Galazka K, Banas T, Popiela T, Lazar A, Kleinrok-Podsiadlo B: Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas. Reprod Biol Endocrinol 2006; 4:41.
20. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 2005; 24:330-334.
21. Wicherek L, Galazka K, Lazar A: The analysis of metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 2007; 65:52-61.
22. Wicherek L, Galazka K, Lazar A: RCAS1 decidual immunoreactivity during placental abruption: Immune cell presence and activity. Am J Reprod Immunol 2007; 58:46-55.
23. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nalano H, Watanabe T: Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995; 6:1099-1104.
24. Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer 2003; 89:546-551.
25. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000; 79:424-429.
26. Sonoda K, Miyamoto S, Nakashima M, Wake N: The biological role of the unique molecule RCAS1: A bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci 2007; 13:1106-1116.
27. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5:938-942.
28. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97:772-779.
29. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol 2005; 99:189-198.
30. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103:924-931.
31. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J Reprod Immunol 2008; 77:100-108.
32. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: Relationship between human tumor-associated antigen RCAS1 and gestational diabetes mellitus. Am J Reprod Immunol 2007; 58:440-446.
33. Dutsch-Wicherek M, Wicherek L: The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas. Am J Reprod Immunol 2008; 59:266-275.
34. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S: Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 2000; 273:654-660.
35. Popiela TJ, Wicherek L, Radwan M, Sikora J, Banas T, Basta P, Kulczycka M, Grabiec M, Obrzut B, Klainka J: The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases. Fol Hist Cytochem 2007; 45(Suppl.1):1-10.
36. Wicherek L, Basta P, Galazka K, Mak P, Dancewicz L, Kalinka J: RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor. Am J Reprod Immunol 2008; 59:152-158.
37. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155:108-112.
38. Abadia-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J Reprod Immunol 1996; 31:109-123.
39. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J Reprod Immunol 2004; 62:125-137.
40. Olson DM, Ammann C: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007; 12:1329-1343.
41. Weiss A, Goldman S, Shalev E: The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 2007; 12: 649-659.
42. Salamonsen LA, Zhang J, Brasted M: Leukocyte networks and human endometrial remodelling. J Reprod Immunol 2002; 57: 95-108.
43. Tabibzadeh S: Molecular control of the implantation window. Hum Reprod Update 1998; 4:465-471.
44. Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G: Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005; 83:598-605.
45. Dimitriadis E, Stoikos C, Stafford-Bell M, Clark I, Paiva P, Kovacs G, Salamonsen LA: Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol 2006; 69:53-64.
46. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoe K, Minakami H, Yamada H: No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 2004; 19:1018-1024.
47. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50:351-354.
48. D'Hooghe TM, Bambra CS, Xiao L, Peixe K, Hill JA: Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus). Am J Obstet Gynecol 2001; 184:917-925.
49. Wu MH, Shoji Y, Wu MC, Chuang PC, Lin CC, Huang MF, Tsai SJ: Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 2005; 167:1061-1069.
50. Zhang C, Maeda N, Izumiya C, Yamamoto Y, Kusume T, Oguri H, Yamashita C, Nishimori Y, Hayashi K, Luo J, Fukaya T: Killer immunoglobulin-like receptor and human leukocyte antigen expression as immundiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol 2006; 55:106-114.
51. Harada T, Taniguchi F, Izawa M, Ohama Y, Takenaka Y, Tagashira Y, Ikeda A, Watanabe A, Iwabe T, Terakawa N: Apoptosis and endometriosis. Front Biosci 2007; 12:3140-3151.
52. Vigano P, Somigliana E, Vignali M, Busacca M, Blasio AM: Genetics of endometriosis: Current status and prospects. Front Biosci 2007; 12:3247-3255.
53. Dmowski WP, Gebel HM, Braun DP: The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand 1994; 159: 7-14.
54. Ordi J, Casals G, Ferrer B, Creus M, Guix C, Palacin A, Campo E, Balasch J: Uterine (CD56+) natural killer cells recrAitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol 2006; 55:369-377.
55. Herrmann Lavoie C, Fraser D, Therriault MJ, Akoum A: Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis. Am J Reprod Immunol 2007; 58:505-513.
56. Kitawaki J, Xu B, Ishihara H, Fukui M, Hasegawa G, Nakamura N, Mizuno S, Ohta M, Obayashi H, Honjo H: Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 2007; 58:481-486.
57. Randall GW, Gantt PA, Poe-Zeigler RL, Bergmann CA, Noel ME, Strawbridge WR, Richardson-Cox B, Hereford JR, Reiff RH: Serum antiendometrial antibodies and diagnosis of endometriosis. Am J Reprod Immunol 2007; 58:374-382.
58. Liu YX: Interaction and signal transduction between oocyte and samatic cells in the ovary. Front Biosci 2007; 12:2782-2796.
59. Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT, Carreras R: The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril 2006; 85:78-83.
60. Maeda N, Izumiya C, Kusum T, Masumoto T, Yamashita C, Yamamoto Y, Oguri H, Fukaya T: Killer inhibitory receptor CD158a overexpression among NK cells in women with endmetriosis is undiminished by laparoscopic surgery and GnRH antagonist treatment. Am J Reprod Immunol 2004; 51:364-372.
61. Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS: Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod 2004; 19:1974-1978.